Biomarker: Mesothelioma

Mesothelin - The novel, non-invasive in vitro biomarker to aid in the diagnosis of Mesothelioma

Mesothelioma is a rare form of cancer that is linked to exposure to asbestos. Although malignant mesothelioma remains a relatively uncommon malignancy, it continues to represent an important cause of mortality in numerous areas worldwide; eg, England, Wales, continental Europe, and Australia. Recent estimates suggest that in coming decades, as much as 1% of deaths among men in the United Kingdom currently aged 49-54 may be due to mesothelioma.1 Age standardized incidence rates for mesothelioma in men range from around 8 per 100,000 in Scotland, England, and The Netherlands; 2-4 per 100,000 in France, Italy, and Germany; and 1 per 100,000 in Spain.2 The corresponding rate for Australia is estimated to be around 6 per 100,000.3 The disease is more likely to occur in men than in women.

There are 3 classifications of mesothelioma:

Pleural — cancer in the chest cavity.

Peritoneal — cancer that starts in the abdomen. (This classification is a form that represents between 10-20% of the mesotheliomas diagnosed.)

Pericardial — cancer in the cavity around the heart. (The most rare form of mesothelioma.)

Lumipulse® G Mesothelin

Unique mono-test immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative determination Soluble Mesothelin Related Peptides (SMRP) in human serum or plasma. The assay utilizes proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in 30 minutes.

Read more here

Welcome to Fujirebio

Please indicate from which location you are connecting:

Once you have made this selection we will show you only the content that is relevant for your country. You can change this setting any time by clicking on the flag in the top toolbar of our website and choosing another country.

More than 50 years of pioneering expertise in IVD


We are a global leader in the field of high quality in vitro diagnostics (IVD) testing. We have more than 50 years’ accumulated experience in the conception, development, production and worldwide commercialization of robust IVD products. Our IVD product lines span the range from specialized manual and automated testing to fully automated routine clinical laboratory testing solutions.


You can change the country filter for contents in our website. You will then see local contact information and other information available for that country. Please choose your country in the list below: